Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Shares Outstanding (Weighted Average) (2020 - 2026)

Lucid Diagnostics filings provide 6 years of Shares Outstanding (Weighted Average) readings, the most recent being $101.9 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 101.81% to $101.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $101.9 million, a 101.81% increase, with the full-year FY2025 number at $101.9 million, up 101.81% from a year prior.
  • Shares Outstanding (Weighted Average) hit $101.9 million in Q4 2025 for Lucid Diagnostics, down from $108.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $108.2 million in Q3 2025 to a low of $14.1 million in Q1 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $41.5 million (2023), compared with a mean of $46.4 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 157.93% in 2022 and later increased 9.87% in 2024.
  • Lucid Diagnostics' Shares Outstanding (Weighted Average) stood at $18.6 million in 2021, then surged by 94.44% to $36.2 million in 2022, then grew by 15.44% to $41.8 million in 2023, then increased by 20.98% to $50.5 million in 2024, then skyrocketed by 101.81% to $101.9 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $101.9 million (Q4 2025), $108.2 million (Q3 2025), and $84.0 million (Q2 2025) per Business Quant data.